Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 832-2886 | query@kbvresearch.com

Global AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component (Software & Platform, and Services), By Technology (Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), and Computer Vision), By End Use, By Application, By Regional Outlook and Forecast, 2025 - 2032

Published Date : 05-Nov-2025

Pages: 600

Report Format: PDF + Excel

COVID-19 Impact on the AI In Drug Repurposing Market

The Global AI In Drug Repurposing Market size is expected to reach $4.11 billion by 2032, rising at a market growth of 19.7% CAGR during the forecast period.

Key Highlights:

  • The North America market dominated Global AI In Drug Repurposing Market in 2024, accounting for a 42.30% revenue share in 2024.
  • The U.S. market is projected to maintain its leadership in North America, reaching a market size of USD 1.31 billion by 2032.
  • Among the Component, the Software & Platform segment dominated the global market, contributing a revenue share of 64.95% in 2024.
  • In terms of Technology, Machine Learning/Deep Learning segment are expected to lead the global market, with a projected revenue share of 40.63% by 2032.
  • The Pharmaceutical & BioTechnology Companies market emerged as the leading End Use in 2024, capturing a 58.41% revenue share, and is projected to retain its dominance during the forecast period.
  • The Oncology Market in Application is poised to grow at the market in 2032 with a market size of USD 1.28 billion and is projected to maintain its dominant position throughout the forecast period.

AI In Drug Repurposing Market Size - Global Opportunities and Trends Analysis Report 2021-2032

The pharmaceutical sector is experiencing a transformative shift as AI revolutionizes drug repurposing-identifying new therapeutic uses for existing compounds. Drug repurposing has developed into a systematic and data-driven approach powered by deep learning, graph-based models, and machine learning. By deploying vast biomedical datasets-including proteomics, clinical records, and genomics, AI now unveils complex drug-disease relationships that were not evident previously. This development has shifted AI-based repurposing from an experimental idea to a mainstream R&D strategy, supported by a strong partnership between technology providers and pharmaceutical companies. AI allows more efficient lifecycle management, enhanced targeting of unmet medical requirements, and faster drug discovery timelines.

The AI in Drug Repurposing market is anticipated to grow, driven by numerous trends. Repurposing is expanding into rescue programs and rare diseases for previously failed molecules, offering strategic as well as humanitarian advantages. Adaptive learning systems now allow continued model updates as new data emerges, improving long-term value and accuracy. Also, AI systems largely manage multimodal data and focus on explainability, providing mechanistic insights that clinical trust and build regulatory confidence. Market players deploy vertical partnerships, hybrid business models, and scalable AI platforms to support innovation. The market is witnessing intensive competition as the landscape is predicted to consolidate around a few integrated AI bio-ecosystems connected to pharma pipelines, with players emphasizing on rare conditions or specific therapeutic.

COVID 19 Impact Analysis

The COVID-19 pandemic sped up the use of AI in drug repurposing a lot, showing how important it is for pharmaceutical R&D. Organizations used AI to quickly screen existing compounds because they needed treatments right away. This cut the time it took to find new drugs from years to weeks. AI models were able to make better predictions because there was more data available on SARS-CoV-2. Preliminary success stories also made investors and the industry more confident. Public-private partnerships and collaborative data-sharing projects added to AI datasets, which led to new ideas for hybrid modeling approaches. As a result, AI repurposing went from being a test project to a key part of modern drug development, showing how it could change things even after the pandemic. Thus, the COVID-19 pandemic had a positive impact on the market.

Technology Outlook

Based on Technology, the market is segmented into Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), and Computer Vision. The natural language processing (NLP) segment witnessed 20% revenue share in the AI In drug repurposing market in 2024.  Natural language processing plays a vital role in extracting insights from unstructured biomedical information such as research papers, patents, and clinical trial reports. NLP algorithms can scan millions of documents to identify potential drug–target or drug–disease connections by interpreting scientific language contextually.

End Use Outlook

Based on End Use, the market is segmented into Pharmaceutical & BioTechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, and Other End Use. The contract research organizations (CROs) segment recorded 20% revenue share in the AI In drug repurposing market in 2024.  Contract research organizations are increasingly adopting AI-based platforms for drug repurposing to support pharmaceutical clients with data processing, clinical insights, and experimental validation. CROs use AI tools to design efficient trial protocols, identify drug candidates with repurposing potential, and model patient responses.

AI In Drug Repurposing Market Share and Industry Analysis Report 2024

Free Valuable Insights: AI In Drug Repurposing Market size to reach USD 4.11 Billion by 2032

Regional Outlook

Region-wise, the AI In Drug Repurposing Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded 42% revenue share in the AI In Drug Repurposing Market in 2024. The AI in Drug Repurposing market is anticipated to grow at a significant rate in North America and Europe. This is due to large investment in pharma R&D, well-established ecosystem of AI startups collaborating CROs and big pharma, and extensive biomedical datasets (real-world evidence, EHRs, and genomics). Furthermore, the European market has strong translational research networks, well-established biotech and pharmaceutical clusters, and growing regulatory interest in AI-based tools, resulting in strong demand. Also, Europe focuses on data privacy deployments and regulatory alignment, which result in surging clinical validation of repurposing candidates.

In the Asia Pacific and LAMEA regions, the AI in Drug Repurposing market is expected to experience substantial expansion. This is driven by rapidly growing R&D spending in India, South Korea, and China, regional health/AI initiatives, rising biomedical data availability, and numerous partnerships between global pharma and regional AI providers. Moreover, the LAMEA region is also witnessing growth due to the rising clinical trial activity and increasing government digital health programs. The global collaborations and private investments target region-specific demands, particularly in nations with strong healthcare infrastructure.

AI In Drug Repurposing Market Report Coverage
Report Attribute Details
Market size value in 2025 USD 1.16 Billion
Market size forecast in 2032 USD 4.11 Billion
Base Year 2024
Historical Period 2021 to 2023
Forecast Period 2025 to 2032
Revenue Growth Rate CAGR of 19.7% from 2025 to 2032
Number of Pages 600
Number of Tables 491
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments covered Component, Technology, End Use, Application, Region
Country scope
  • North America (US, Canada, Mexico, and Rest of North America)
  • Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe)
  • Asia Pacific (Japan, China, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific)
  • LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included

Ginkgo Bioworks Holdings, Inc., IBM Corporation, Atomwise, Inc., Cyclica, Inc., Genesis Healthcare Co., Verge, Inc., Novartis AG, Schrödinger, Inc, Recursion Pharmaceuticals, Inc., and The Cradle Company

List of Key Companies Profiled

  • Ginkgo Bioworks Holdings, Inc.
  • IBM Corporation
  • Atomwise, Inc.
  • Cyclica, Inc.
  • Genesis Healthcare Co.
  • Verge, Inc.
  • Novartis AG
  • Schrödinger, Inc
  • Recursion Pharmaceuticals, Inc.
  • The Cradle Company

AI In Drug Repurposing Market Report Segmentation

By Component

  • Software & Platform
  • Services

By Technology

  • Machine Learning/Deep Learning
  • Natural Language Processing (NLP)
  • Knowledge Graphs & Network-Based AI
  • Generative AI & Large Language Models (LLMs)
  • Computer Vision

By End Use

  • Pharmaceutical & BioTechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Other End Use

By Application

  • Oncology
  • Neurology
  • Infectious Diseases
  • Rare & Orphan Diseases
  • Cardiology
  • Other Application

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global AI In Drug Repurposing Market, by Component
1.4.2 Global AI In Drug Repurposing Market, by Technology
1.4.3 Global AI In Drug Repurposing Market, by End Use
1.4.4 Global AI In Drug Repurposing Market, by Application
1.4.5 Global AI In Drug Repurposing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario 
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Market Trends – AI In Drug Repurposing Market
Chapter 5. State of Competition - AI In Drug Repurposing Market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. Global AI In Drug Repurposing Market by Component
10.1 Global Software & Platform Market by Region
10.2 Global Services Market by Region

Chapter 11. Global AI In Drug Repurposing Market by Technology
11.1 Global Machine Learning/Deep Learning Market by Region
11.2 Global Natural Language Processing (NLP) Market by Region
11.3 Global Knowledge Graphs & Network-Based AI Market by Region
11.4 Global Generative AI & Large Language Models (LLMs) Market by Region
11.5 Global Computer Vision Market by Region

Chapter 12. Global AI In Drug Repurposing Market by End Use
12.1 Global Pharmaceutical & BioTechnology Companies Market by Region
12.2 Global Contract Research Organizations (CROs) Market by Region
12.3 Global Academic & Research Institutes Market by Region
12.4 Global Other End Use Market by Region

Chapter 13. Global AI In Drug Repurposing Market by Application
13.1 Global Oncology Market by Region
13.2 Global Neurology Market by Region
13.3 Global Infectious Diseases Market by Region
13.4 Global Rare & Orphan Diseases Market by Region
13.5 Global Cardiology Market by Region
13.6 Global Other Application Market by Region

Chapter 14. Global AI In Drug Repurposing Market by Region
14.1 North America AI In Drug Repurposing Market
14.2 Key Factors Impacting the Market
14.2.1 Market Drivers
14.2.2 Market Restraints
14.2.3 Market Opportunities
14.2.4 Market Challenges
14.2.5 Market Trends – North America AI In Drug Repurposing Market
14.2.6 State of Competition - North American AI in Drug Repurposing Market
14.2.7 North America AI In Drug Repurposing Market by Component
14.2.7.1 North America Software & Platform Market by Country
14.2.7.2 North America Services Market by Country
14.2.8 North America AI In Drug Repurposing Market by Technology
14.2.8.1 North America Machine Learning/Deep Learning Market by Region
14.2.8.2 North America Natural Language Processing (NLP) Market by Region
14.2.8.3 North America Knowledge Graphs & Network-Based AI Market by Region
14.2.8.4 North America Generative AI & Large Language Models (LLMs) Market by Region
14.2.8.5 North America Computer Vision Market by Region
14.2.9 North America AI In Drug Repurposing Market by End Use
14.2.9.1 North America Pharmaceutical & BioTechnology Companies Market by Country
14.2.9.2 North America Contract Research Organizations (CROs) Market by Country
14.2.9.3 North America Academic & Research Institutes Market by Country
14.2.9.4 North America Other End Use Market by Country
14.2.10 North America AI In Drug Repurposing Market by Application
14.2.10.1 North America Oncology Market by Country
14.2.10.2 North America Neurology Market by Country
14.2.10.3 North America Infectious Diseases Market by Country
14.2.10.4 North America Rare & Orphan Diseases Market by Country
14.2.10.5 North America Cardiology Market by Country
14.2.10.6 North America Other Application Market by Country
14.2.11 North America AI In Drug Repurposing Market by Country
14.2.11.1 US AI In Drug Repurposing Market
14.2.11.1.1 US AI In Drug Repurposing Market by Component
14.2.11.1.2 US AI In Drug Repurposing Market by Technology
14.2.11.1.3 US AI In Drug Repurposing Market by End Use
14.2.11.1.4 US AI In Drug Repurposing Market by Application
14.2.11.2 Canada AI In Drug Repurposing Market
14.2.11.2.1 Canada AI In Drug Repurposing Market by Component
14.2.11.2.2 Canada AI In Drug Repurposing Market by Technology
14.2.11.2.3 Canada AI In Drug Repurposing Market by End Use
14.2.11.2.4 Canada AI In Drug Repurposing Market by Application
14.2.11.3 Mexico AI In Drug Repurposing Market
14.2.11.3.1 Mexico AI In Drug Repurposing Market by Component
14.2.11.3.2 Mexico AI In Drug Repurposing Market by Technology
14.2.11.3.3 Mexico AI In Drug Repurposing Market by End Use
14.2.11.3.4 Mexico AI In Drug Repurposing Market by Application
14.2.11.4 Rest of North America AI In Drug Repurposing Market
14.2.11.4.1 Rest of North America AI In Drug Repurposing Market by Component
14.2.11.4.2 Rest of North America AI In Drug Repurposing Market by Technology
14.2.11.4.3 Rest of North America AI In Drug Repurposing Market by End Use
14.2.11.4.4 Rest of North America AI In Drug Repurposing Market by Application
14.3 Europe AI In Drug Repurposing Market
14.4 Key Factors Impacting the Market
14.4.1 Market Drivers
14.4.2 Market Restraints
14.4.3 Market Opportunities
14.4.4 Market Challenges
14.4.5 Market Trends – Europe AI In Drug Repurposing Market
14.4.6 State of Competition - Europe AI in Drug Repurposing market
14.4.7 Europe AI In Drug Repurposing Market by Component
14.4.7.1 Europe Software & Platform Market by Country
14.4.7.2 Europe Services Market by Country
14.4.8 Europe AI In Drug Repurposing Market by Technology
14.4.8.1 Europe Machine Learning/Deep Learning Market by Country
14.4.8.2 Europe Natural Language Processing (NLP) Market by Country
14.4.8.3 Europe Knowledge Graphs & Network-Based AI Market by Country
14.4.8.4 Europe Generative AI & Large Language Models (LLMs) Market by Country
14.4.8.5 Europe Computer Vision Market by Country
14.4.9 Europe AI In Drug Repurposing Market by End Use
14.4.9.1 Europe Pharmaceutical & BioTechnology Companies Market by Country
14.4.9.2 Europe Contract Research Organizations (CROs) Market by Country
14.4.9.3 Europe Academic & Research Institutes Market by Country
14.4.9.4 Europe Other End Use Market by Country
14.4.10 Europe AI In Drug Repurposing Market by Application
14.4.10.1 Europe Oncology Market by Country
14.4.10.2 Europe Neurology Market by Country
14.4.10.3 Europe Infectious Diseases Market by Country
14.4.10.4 Europe Rare & Orphan Diseases Market by Country
14.4.10.5 Europe Cardiology Market by Country
14.4.10.6 Europe Other Application Market by Country
14.4.11 Europe AI In Drug Repurposing Market by Country
14.4.11.1 Germany AI In Drug Repurposing Market
14.4.11.1.1 Germany AI In Drug Repurposing Market by Component
14.4.11.1.2 Germany AI In Drug Repurposing Market by Technology
14.4.11.1.3 Germany AI In Drug Repurposing Market by End Use
14.4.11.1.4 Germany AI In Drug Repurposing Market by Application
14.4.11.2 UK AI In Drug Repurposing Market
14.4.11.2.1 UK AI In Drug Repurposing Market by Component
14.4.11.2.2 UK AI In Drug Repurposing Market by Technology
14.4.11.2.3 UK AI In Drug Repurposing Market by End Use
14.4.11.2.4 UK AI In Drug Repurposing Market by Application
14.4.11.3 France AI In Drug Repurposing Market
14.4.11.3.1 France AI In Drug Repurposing Market by Component
14.4.11.3.2 France AI In Drug Repurposing Market by Technology
14.4.11.3.3 France AI In Drug Repurposing Market by End Use
14.4.11.3.4 France AI In Drug Repurposing Market by Application
14.4.11.4 Russia AI In Drug Repurposing Market
14.4.11.4.1 Russia AI In Drug Repurposing Market by Component
14.4.11.4.2 Russia AI In Drug Repurposing Market by Technology
14.4.11.4.3 Russia AI In Drug Repurposing Market by End Use
14.4.11.4.4 Russia AI In Drug Repurposing Market by Application
14.4.11.5 Spain AI In Drug Repurposing Market
14.4.11.5.1 Spain AI In Drug Repurposing Market by Component
14.4.11.5.2 Spain AI In Drug Repurposing Market by Technology
14.4.11.5.3 Spain AI In Drug Repurposing Market by End Use
14.4.11.5.4 Spain AI In Drug Repurposing Market by Application
14.4.11.6 Italy AI In Drug Repurposing Market
14.4.11.6.1 Italy AI In Drug Repurposing Market by Component
14.4.11.6.2 Italy AI In Drug Repurposing Market by Technology
14.4.11.6.3 Italy AI In Drug Repurposing Market by End Use
14.4.11.6.4 Italy AI In Drug Repurposing Market by Application
14.4.11.7 Rest of Europe AI In Drug Repurposing Market
14.4.11.7.1 Rest of Europe AI In Drug Repurposing Market by Component
14.4.11.7.2 Rest of Europe AI In Drug Repurposing Market by Technology
14.4.11.7.3 Rest of Europe AI In Drug Repurposing Market by End Use
14.4.11.7.4 Rest of Europe AI In Drug Repurposing Market by Application
14.5 Asia Pacific AI In Drug Repurposing Market
14.6 Key Factors Impacting the Market
14.6.1 Market Drivers
14.6.2 Market Restraints
14.6.3 Market Opportunities
14.6.4 Market Challenges
14.6.5 Market Trends – Asia Pacific AI In Drug Repurposing Market
14.6.6 State of Competition – Asia Pacific AI In Drug Repurposing Market
14.6.7 Asia Pacific AI In Drug Repurposing Market by Component
14.6.7.1 Asia Pacific Software & Platform Market by Country
14.6.7.2 Asia Pacific Services Market by Country
14.6.8 Asia Pacific AI In Drug Repurposing Market by Technology
14.6.8.1 Asia Pacific Machine Learning/Deep Learning Market by Country
14.6.8.2 Asia Pacific Natural Language Processing (NLP) Market by Country
14.6.8.3 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country
14.6.8.4 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country
14.6.8.5 Asia Pacific Computer Vision Market by Country
14.6.9 Asia Pacific AI In Drug Repurposing Market by End Use
14.6.9.1 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country
14.6.9.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
14.6.9.3 Asia Pacific Academic & Research Institutes Market by Country
14.6.9.4 Asia Pacific Other End Use Market by Country
14.6.10 Asia Pacific AI In Drug Repurposing Market by Application
14.6.10.1 Asia Pacific Oncology Market by Country
14.6.10.2 Asia Pacific Neurology Market by Country
14.6.10.3 Asia Pacific Infectious Diseases Market by Country
14.6.10.4 Asia Pacific Rare & Orphan Diseases Market by Country
14.6.10.5 Asia Pacific Cardiology Market by Country
14.6.10.6 Asia Pacific Other Application Market by Country
14.6.11 Asia Pacific AI In Drug Repurposing Market by Country
14.6.11.1 China AI In Drug Repurposing Market
14.6.11.1.1 China AI In Drug Repurposing Market by Component
14.6.11.1.2 China AI In Drug Repurposing Market by Technology
14.6.11.1.3 China AI In Drug Repurposing Market by End Use
14.6.11.1.4 China AI In Drug Repurposing Market by Application
14.6.11.2 Japan AI In Drug Repurposing Market
14.6.11.2.1 Japan AI In Drug Repurposing Market by Component
14.6.11.2.2 Japan AI In Drug Repurposing Market by Technology
14.6.11.2.3 Japan AI In Drug Repurposing Market by End Use
14.6.11.2.4 Japan AI In Drug Repurposing Market by Application
14.6.11.3 India AI In Drug Repurposing Market
14.6.11.3.1 India AI In Drug Repurposing Market by Component
14.6.11.3.2 India AI In Drug Repurposing Market by Technology
14.6.11.3.3 India AI In Drug Repurposing Market by End Use
14.6.11.3.4 India AI In Drug Repurposing Market by Application
14.6.11.4 South Korea AI In Drug Repurposing Market
14.6.11.4.1 South Korea AI In Drug Repurposing Market by Component
14.6.11.4.2 South Korea AI In Drug Repurposing Market by Technology
14.6.11.4.3 South Korea AI In Drug Repurposing Market by End Use
14.6.11.4.4 South Korea AI In Drug Repurposing Market by Application
14.6.11.5 Singapore AI In Drug Repurposing Market
14.6.11.5.1 Singapore AI In Drug Repurposing Market by Component
14.6.11.5.2 Singapore AI In Drug Repurposing Market by Technology
14.6.11.5.3 Singapore AI In Drug Repurposing Market by End Use
14.6.11.5.4 Singapore AI In Drug Repurposing Market by Application
14.6.11.6 Malaysia AI In Drug Repurposing Market
14.6.11.6.1 Malaysia AI In Drug Repurposing Market by Component
14.6.11.6.2 Malaysia AI In Drug Repurposing Market by Technology
14.6.11.6.3 Malaysia AI In Drug Repurposing Market by End Use
14.6.11.6.4 Malaysia AI In Drug Repurposing Market by Application
14.6.11.7 Rest of Asia Pacific AI In Drug Repurposing Market
14.6.11.7.1 Rest of Asia Pacific AI In Drug Repurposing Market by Component
14.6.11.7.2 Rest of Asia Pacific AI In Drug Repurposing Market by Technology
14.6.11.7.3 Rest of Asia Pacific AI In Drug Repurposing Market by End Use
14.6.11.7.4 Rest of Asia Pacific AI In Drug Repurposing Market by Application
14.7 LAMEA AI In Drug Repurposing Market
14.8 Key Factors Impacting the Market
14.8.1 Market Drivers
14.8.2 Market Restraints
14.8.3 Market Opportunities
14.8.4 Market Challenges
14.8.5 Market Trends – LAMEA AI In Drug Repurposing Market
14.8.6 State of Competition - LAMEA AI in Drug Repurposing market
14.8.7 LAMEA AI In Drug Repurposing Market by Component
14.8.7.1 LAMEA Software & Platform Market by Country
14.8.7.2 LAMEA Services Market by Country
14.8.8 LAMEA AI In Drug Repurposing Market by Technology
14.8.8.1 LAMEA Machine Learning/Deep Learning Market by Country
14.8.8.2 LAMEA Natural Language Processing (NLP) Market by Country
14.8.8.3 LAMEA Knowledge Graphs & Network-Based AI Market by Country
14.8.8.4 LAMEA Generative AI & Large Language Models (LLMs) Market by Country
14.8.8.5 LAMEA Computer Vision Market by Country
14.8.9 LAMEA AI In Drug Repurposing Market by End Use
14.8.9.1 LAMEA Pharmaceutical & BioTechnology Companies Market by Country
14.8.9.2 LAMEA Contract Research Organizations (CROs) Market by Country
14.8.9.3 LAMEA Academic & Research Institutes Market by Country
14.8.9.4 LAMEA Other End Use Market by Country
14.8.10 LAMEA AI In Drug Repurposing Market by Application
14.8.10.1 LAMEA Oncology Market by Country
14.8.10.2 LAMEA Neurology Market by Country
14.8.10.3 LAMEA Infectious Diseases Market by Country
14.8.10.4 LAMEA Rare & Orphan Diseases Market by Country
14.8.10.5 LAMEA Cardiology Market by Country
14.8.10.6 LAMEA Other Application Market by Country
14.8.11 LAMEA AI In Drug Repurposing Market by Country
14.8.11.1 Brazil AI In Drug Repurposing Market
14.8.11.1.1 Brazil AI In Drug Repurposing Market by Component
14.8.11.1.2 Brazil AI In Drug Repurposing Market by Technology
14.8.11.1.3 Brazil AI In Drug Repurposing Market by End Use
14.8.11.1.4 Brazil AI In Drug Repurposing Market by Application
14.8.11.2 Argentina AI In Drug Repurposing Market
14.8.11.2.1 Argentina AI In Drug Repurposing Market by Component
14.8.11.2.2 Argentina AI In Drug Repurposing Market by Technology
14.8.11.2.3 Argentina AI In Drug Repurposing Market by End Use
14.8.11.2.4 Argentina AI In Drug Repurposing Market by Application
14.8.11.3 UAE AI In Drug Repurposing Market
14.8.11.3.1 UAE AI In Drug Repurposing Market by Component
14.8.11.3.2 UAE AI In Drug Repurposing Market by Technology
14.8.11.3.3 UAE AI In Drug Repurposing Market by End Use
14.8.11.3.4 UAE AI In Drug Repurposing Market by Application
14.8.11.4 Saudi Arabia AI In Drug Repurposing Market
14.8.11.4.1 Saudi Arabia AI In Drug Repurposing Market by Component
14.8.11.4.2 Saudi Arabia AI In Drug Repurposing Market by Technology
14.8.11.4.3 Saudi Arabia AI In Drug Repurposing Market by End Use
14.8.11.4.4 Saudi Arabia AI In Drug Repurposing Market by Application
14.8.11.5 South Africa AI In Drug Repurposing Market
14.8.11.5.1 South Africa AI In Drug Repurposing Market by Component
14.8.11.5.2 South Africa AI In Drug Repurposing Market by Technology
14.8.11.5.3 South Africa AI In Drug Repurposing Market by End Use
14.8.11.5.4 South Africa AI In Drug Repurposing Market by Application
14.8.11.6 Nigeria AI In Drug Repurposing Market
14.8.11.6.1 Nigeria AI In Drug Repurposing Market by Component
14.8.11.6.2 Nigeria AI In Drug Repurposing Market by Technology
14.8.11.6.3 Nigeria AI In Drug Repurposing Market by End Use
14.8.11.6.4 Nigeria AI In Drug Repurposing Market by Application
14.8.11.7 Rest of LAMEA AI In Drug Repurposing Market
14.8.11.7.1 Rest of LAMEA AI In Drug Repurposing Market by Component
14.8.11.7.2 Rest of LAMEA AI In Drug Repurposing Market by Technology
14.8.11.7.3 Rest of LAMEA AI In Drug Repurposing Market by End Use
14.8.11.7.4 Rest of LAMEA AI In Drug Repurposing Market by Application

Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview

Chapter 16. Winning Imperatives of AI In Drug Repurposing Market
TABLE 1 Global AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 2 Global AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 3 Key Customer Criteria and Ratings for AI in Drug Repurposing Market
TABLE 4 Global AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 5 Global AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 6 Global Software & Platform Market by Region, 2021 - 2024, USD Million
TABLE 7 Global Software & Platform Market by Region, 2025 - 2032, USD Million
TABLE 8 Global Services Market by Region, 2021 - 2024, USD Million
TABLE 9 Global Services Market by Region, 2025 - 2032, USD Million
TABLE 10 Global AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 11 Global AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 12 Global Machine Learning/Deep Learning Market by Region, 2021 - 2024, USD Million
TABLE 13 Global Machine Learning/Deep Learning Market by Region, 2025 - 2032, USD Million
TABLE 14 Global Natural Language Processing (NLP) Market by Region, 2021 - 2024, USD Million
TABLE 15 Global Natural Language Processing (NLP) Market by Region, 2025 - 2032, USD Million
TABLE 16 Global Knowledge Graphs & Network-Based AI Market by Region, 2021 - 2024, USD Million
TABLE 17 Global Knowledge Graphs & Network-Based AI Market by Region, 2025 - 2032, USD Million
TABLE 18 Global Generative AI & Large Language Models (LLMs) Market by Region, 2021 - 2024, USD Million
TABLE 19 Global Generative AI & Large Language Models (LLMs) Market by Region, 2025 - 2032, USD Million
TABLE 20 Global Computer Vision Market by Region, 2021 - 2024, USD Million
TABLE 21 Global Computer Vision Market by Region, 2025 - 2032, USD Million
TABLE 22 Global AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 23 Global AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 24 Global Pharmaceutical & BioTechnology Companies Market by Region, 2021 - 2024, USD Million
TABLE 25 Global Pharmaceutical & BioTechnology Companies Market by Region, 2025 - 2032, USD Million
TABLE 26 Global Contract Research Organizations (CROs) Market by Region, 2021 - 2024, USD Million
TABLE 27 Global Contract Research Organizations (CROs) Market by Region, 2025 - 2032, USD Million
TABLE 28 Global Academic & Research Institutes Market by Region, 2021 - 2024, USD Million
TABLE 29 Global Academic & Research Institutes Market by Region, 2025 - 2032, USD Million
TABLE 30 Global Other End Use Market by Region, 2021 - 2024, USD Million
TABLE 31 Global Other End Use Market by Region, 2025 - 2032, USD Million
TABLE 32 Global AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 33 Global AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 34 Global Oncology Market by Region, 2021 - 2024, USD Million
TABLE 35 Global Oncology Market by Region, 2025 - 2032, USD Million
TABLE 36 Global Neurology Market by Region, 2021 - 2024, USD Million
TABLE 37 Global Neurology Market by Region, 2025 - 2032, USD Million
TABLE 38 Global Infectious Diseases Market by Region, 2021 - 2024, USD Million
TABLE 39 Global Infectious Diseases Market by Region, 2025 - 2032, USD Million
TABLE 40 Global Rare & Orphan Diseases Market by Region, 2021 - 2024, USD Million
TABLE 41 Global Rare & Orphan Diseases Market by Region, 2025 - 2032, USD Million
TABLE 42 Global Cardiology Market by Region, 2021 - 2024, USD Million
TABLE 43 Global Cardiology Market by Region, 2025 - 2032, USD Million
TABLE 44 Global Other Application Market by Region, 2021 - 2024, USD Million
TABLE 45 Global Other Application Market by Region, 2025 - 2032, USD Million
TABLE 46 Global AI In Drug Repurposing Market by Region, 2021 - 2024, USD Million
TABLE 47 Global AI In Drug Repurposing Market by Region, 2025 - 2032, USD Million
TABLE 48 North America AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 49 North America AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 50 North America AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 51 North America AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 52 North America Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 53 North America Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 54 North America Services Market by Country, 2021 - 2024, USD Million
TABLE 55 North America Services Market by Country, 2025 - 2032, USD Million
TABLE 56 North America AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 57 North America AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 58 North America Machine Learning/Deep Learning Market by Region, 2021 - 2024, USD Million
TABLE 59 North America Machine Learning/Deep Learning Market by Region, 2025 - 2032, USD Million
TABLE 60 North America Natural Language Processing (NLP) Market by Region, 2021 - 2024, USD Million
TABLE 61 North America Natural Language Processing (NLP) Market by Region, 2025 - 2032, USD Million
TABLE 62 North America Knowledge Graphs & Network-Based AI Market by Region, 2021 - 2024, USD Million
TABLE 63 North America Knowledge Graphs & Network-Based AI Market by Region, 2025 - 2032, USD Million
TABLE 64 North America Generative AI & Large Language Models (LLMs) Market by Region, 2021 - 2024, USD Million
TABLE 65 North America Generative AI & Large Language Models (LLMs) Market by Region, 2025 - 2032, USD Million
TABLE 66 North America Computer Vision Market by Region, 2021 - 2024, USD Million
TABLE 67 North America Computer Vision Market by Region, 2025 - 2032, USD Million
TABLE 68 North America AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 69 North America AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 70 North America Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 71 North America Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 72 North America Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 73 North America Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 74 North America Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 75 North America Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 76 North America Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 77 North America Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 78 North America AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 79 North America AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 80 North America Oncology Market by Country, 2021 - 2024, USD Million
TABLE 81 North America Oncology Market by Country, 2025 - 2032, USD Million
TABLE 82 North America Neurology Market by Country, 2021 - 2024, USD Million
TABLE 83 North America Neurology Market by Country, 2025 - 2032, USD Million
TABLE 84 North America Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 85 North America Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 86 North America Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 87 North America Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 88 North America Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 89 North America Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 90 North America Other Application Market by Country, 2021 - 2024, USD Million
TABLE 91 North America Other Application Market by Country, 2025 - 2032, USD Million
TABLE 92 North America AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 93 North America AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 94 US AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 95 US AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 96 US AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 97 US AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 98 US AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 99 US AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 100 US AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 101 US AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 102 US AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 103 US AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 104 Canada AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 105 Canada AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 106 Canada AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 107 Canada AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 108 Canada AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 109 Canada AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 110 Canada AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 111 Canada AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 112 Canada AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 113 Canada AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 114 Mexico AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 115 Mexico AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 116 Mexico AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 117 Mexico AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 118 Mexico AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 119 Mexico AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 120 Mexico AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 121 Mexico AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 122 Mexico AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 123 Mexico AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 124 Rest of North America AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 125 Rest of North America AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 126 Rest of North America AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 127 Rest of North America AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 128 Rest of North America AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 129 Rest of North America AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 130 Rest of North America AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 131 Rest of North America AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 132 Rest of North America AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 133 Rest of North America AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 134 Europe AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 135 Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 136 Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 137 Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 138 Europe Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 139 Europe Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 140 Europe Services Market by Country, 2021 - 2024, USD Million
TABLE 141 Europe Services Market by Country, 2025 - 2032, USD Million
TABLE 142 Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 143 Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 144 Europe Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 145 Europe Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 146 Europe Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
TABLE 147 Europe Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
TABLE 148 Europe Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
TABLE 149 Europe Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
TABLE 150 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
TABLE 151 Europe Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
TABLE 152 Europe Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 153 Europe Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 154 Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 155 Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 156 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 157 Europe Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 158 Europe Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 159 Europe Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 160 Europe Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 161 Europe Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 162 Europe Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 163 Europe Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 164 Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 165 Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 166 Europe Oncology Market by Country, 2021 - 2024, USD Million
TABLE 167 Europe Oncology Market by Country, 2025 - 2032, USD Million
TABLE 168 Europe Neurology Market by Country, 2021 - 2024, USD Million
TABLE 169 Europe Neurology Market by Country, 2025 - 2032, USD Million
TABLE 170 Europe Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 171 Europe Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 172 Europe Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 173 Europe Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 174 Europe Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 175 Europe Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 176 Europe Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 177 Europe Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 178 Europe AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 179 Europe AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 180 Germany AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 181 Germany AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 182 Germany AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 183 Germany AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 184 Germany AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 185 Germany AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 186 Germany AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 187 Germany AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 188 Germany AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 189 Germany AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 190 UK AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 191 UK AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 192 UK AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 193 UK AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 194 UK AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 195 UK AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 196 UK AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 197 UK AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 198 UK AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 199 UK AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 200 France AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 201 France AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 202 France AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 203 France AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 204 France AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 205 France AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 206 France AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 207 France AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 208 France AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 209 France AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 210 Russia AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 211 Russia AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 212 Russia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 213 Russia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 214 Russia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 215 Russia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 216 Russia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 217 Russia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 218 Russia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 219 Russia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 220 Spain AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 221 Spain AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 222 Spain AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 223 Spain AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 224 Spain AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 225 Spain AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 226 Spain AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 227 Spain AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 228 Spain AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 229 Spain AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 230 Italy AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 231 Italy AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 232 Italy AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 233 Italy AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 234 Italy AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 235 Italy AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 236 Italy AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 237 Italy AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 238 Italy AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 239 Italy AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 240 Rest of Europe AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 241 Rest of Europe AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 242 Rest of Europe AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 243 Rest of Europe AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 244 Rest of Europe AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 245 Rest of Europe AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 246 Rest of Europe AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 247 Rest of Europe AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 248 Rest of Europe AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 249 Rest of Europe AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 250 Asia Pacific AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 251 Asia Pacific AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 252 Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 253 Asia Pacific AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 254 Asia Pacific Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 255 Asia Pacific Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 256 Asia Pacific Services Market by Country, 2021 - 2024, USD Million
TABLE 257 Asia Pacific Services Market by Country, 2025 - 2032, USD Million
TABLE 258 Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 259 Asia Pacific AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 260 Asia Pacific Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 261 Asia Pacific Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 262 Asia Pacific Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
TABLE 263 Asia Pacific Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
TABLE 264 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
TABLE 265 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
TABLE 266 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
TABLE 267 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
TABLE 268 Asia Pacific Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 269 Asia Pacific Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 270 Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 271 Asia Pacific AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 272 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 273 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 274 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 275 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 276 Asia Pacific Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 277 Asia Pacific Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 278 Asia Pacific Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 279 Asia Pacific Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 280 Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 281 Asia Pacific AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 282 Asia Pacific Oncology Market by Country, 2021 - 2024, USD Million
TABLE 283 Asia Pacific Oncology Market by Country, 2025 - 2032, USD Million
TABLE 284 Asia Pacific Neurology Market by Country, 2021 - 2024, USD Million
TABLE 285 Asia Pacific Neurology Market by Country, 2025 - 2032, USD Million
TABLE 286 Asia Pacific Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 287 Asia Pacific Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 288 Asia Pacific Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 289 Asia Pacific Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 290 Asia Pacific Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 291 Asia Pacific Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 292 Asia Pacific Other Application Market by Country, 2021 - 2024, USD Million
TABLE 293 Asia Pacific Other Application Market by Country, 2025 - 2032, USD Million
TABLE 294 Asia Pacific AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 295 Asia Pacific AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 296 China AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 297 China AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 298 China AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 299 China AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 300 China AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 301 China AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 302 China AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 303 China AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 304 China AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 305 China AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 306 Japan AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 307 Japan AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 308 Japan AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 309 Japan AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 310 Japan AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 311 Japan AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 312 Japan AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 313 Japan AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 314 Japan AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 315 Japan AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 316 India AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 317 India AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 318 India AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 319 India AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 320 India AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 321 India AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 322 India AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 323 India AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 324 India AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 325 India AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 326 South Korea AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 327 South Korea AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 328 South Korea AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 329 South Korea AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 330 South Korea AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 331 South Korea AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 332 South Korea AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 333 South Korea AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 334 South Korea AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 335 South Korea AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 336 Singapore AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 337 Singapore AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 338 Singapore AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 339 Singapore AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 340 Singapore AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 341 Singapore AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 342 Singapore AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 343 Singapore AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 344 Singapore AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 345 Singapore AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 346 Malaysia AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 347 Malaysia AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 348 Malaysia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 349 Malaysia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 350 Malaysia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 351 Malaysia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 352 Malaysia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 353 Malaysia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 354 Malaysia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 355 Malaysia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 356 Rest of Asia Pacific AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 357 Rest of Asia Pacific AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 358 Rest of Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 359 Rest of Asia Pacific AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 360 Rest of Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 361 Rest of Asia Pacific AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 362 Rest of Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 363 Rest of Asia Pacific AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 364 Rest of Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 365 Rest of Asia Pacific AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 366 LAMEA AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 367 LAMEA AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 368 LAMEA AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 369 LAMEA AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 370 LAMEA Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 371 LAMEA Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 372 LAMEA Services Market by Country, 2021 - 2024, USD Million
TABLE 373 LAMEA Services Market by Country, 2025 - 2032, USD Million
TABLE 374 LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 375 LAMEA AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 376 LAMEA Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 377 LAMEA Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 378 LAMEA Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
TABLE 379 LAMEA Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
TABLE 380 LAMEA Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
TABLE 381 LAMEA Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
TABLE 382 LAMEA Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
TABLE 383 LAMEA Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
TABLE 384 LAMEA Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 385 LAMEA Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 386 LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 387 LAMEA AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 388 LAMEA Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 389 LAMEA Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 390 LAMEA Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 391 LAMEA Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 392 LAMEA Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 393 LAMEA Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 394 LAMEA Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 395 LAMEA Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 396 LAMEA AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 397 LAMEA AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 398 LAMEA Oncology Market by Country, 2021 - 2024, USD Million
TABLE 399 LAMEA Oncology Market by Country, 2025 - 2032, USD Million
TABLE 400 LAMEA Neurology Market by Country, 2021 - 2024, USD Million
TABLE 401 LAMEA Neurology Market by Country, 2025 - 2032, USD Million
TABLE 402 LAMEA Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 403 LAMEA Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 404 LAMEA Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 405 LAMEA Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 406 LAMEA Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 407 LAMEA Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 408 LAMEA Other Application Market by Country, 2021 - 2024, USD Million
TABLE 409 LAMEA Other Application Market by Country, 2025 - 2032, USD Million
TABLE 410 LAMEA AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 411 LAMEA AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 412 Brazil AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 413 Brazil AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 414 Brazil AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 415 Brazil AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 416 Brazil AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 417 Brazil AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 418 Brazil AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 419 Brazil AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 420 Brazil AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 421 Brazil AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 422 Argentina AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 423 Argentina AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 424 Argentina AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 425 Argentina AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 426 Argentina AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 427 Argentina AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 428 Argentina AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 429 Argentina AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 430 Argentina AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 431 Argentina AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 432 UAE AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 433 UAE AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 434 UAE AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 435 UAE AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 436 UAE AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 437 UAE AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 438 UAE AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 439 UAE AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 440 UAE AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 441 UAE AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 442 Saudi Arabia AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 443 Saudi Arabia AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 444 Saudi Arabia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 445 Saudi Arabia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 446 Saudi Arabia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 447 Saudi Arabia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 448 Saudi Arabia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 449 Saudi Arabia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 450 Saudi Arabia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 451 Saudi Arabia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 452 South Africa AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 453 South Africa AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 454 South Africa AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 455 South Africa AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 456 South Africa AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 457 South Africa AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 458 South Africa AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 459 South Africa AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 460 South Africa AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 461 South Africa AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 462 Nigeria AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 463 Nigeria AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 464 Nigeria AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 465 Nigeria AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 466 Nigeria AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 467 Nigeria AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 468 Nigeria AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 469 Nigeria AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 470 Nigeria AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 471 Nigeria AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 472 Rest of LAMEA AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 473 Rest of LAMEA AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 474 Rest of LAMEA AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 475 Rest of LAMEA AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 476 Rest of LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 477 Rest of LAMEA AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 478 Rest of LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 479 Rest of LAMEA AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 480 Rest of LAMEA AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 481 Rest of LAMEA AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 482 Key Information – GINKGO BIOWORKS HOLDINGS, INC.
TABLE 483 Key Information – IBM Corporation
TABLE 484 Key Information – Atomwise, Inc.
TABLE 485 Key Information – Cyclica, Inc.
TABLE 486 Key Information – Genesis Healthcare Co.
TABLE 487 Key Information – Verge, Inc.
TABLE 488 Key Information – Novartis AG
TABLE 489 Key Information – Schrödinger, Inc
TABLE 490 Key Information – Recursion Pharmaceuticals, Inc.
TABLE 491 Key Information – The Cradle Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Global AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting AI In Drug Repurposing Market
FIG 4 Porter’s Five Forces Analysis – AI In Drug Repurposing Market
FIG 5 Value Chain Analysis of AI In Drug Repurposing Market
FIG 6 Product Life Cycle – AI In Drug Repurposing Market
FIG 7 Market Consolidation – AI In Drug Repurposing Market
FIG 8 Key Customer Criteria – AI In Drug Repurposing Market
FIG 9 Global AI In Drug Repurposing Market share by Component, 2024
FIG 10 Global AI In Drug Repurposing Market share by Component, 2032
FIG 11 Global AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 12 Global AI In Drug Repurposing Market share by Technology, 2024
FIG 13 Global AI In Drug Repurposing Market share by Technology, 2032
FIG 14 Global AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 15 Global AI In Drug Repurposing Market share by End Use, 2024
FIG 16 Global AI In Drug Repurposing Market share by End Use, 2032
FIG 17 Global AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 18 Global AI In Drug Repurposing Market share by Application, 2024
FIG 19 Global AI In Drug Repurposing Market share by Application, 2032
FIG 20 Global AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 21 Global AI In Drug Repurposing Market share by Region, 2024
FIG 22 Global AI In Drug Repurposing Market share by Region, 2032
FIG 23 Global AI In Drug Repurposing Market by Region, 2021 - 2032, USD Million
FIG 24 Key Factors Impacting north America AI In Drug Repurposing Market
FIG 25 North America AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 26 North America AI In Drug Repurposing Market share by Component, 2024
FIG 27 North America AI In Drug Repurposing Market share by Component, 2032
FIG 28 North America AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 29 North America AI In Drug Repurposing Market share by Technology, 2024
FIG 30 North America AI In Drug Repurposing Market share by Technology, 2032
FIG 31 North America AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 32 North America AI In Drug Repurposing Market share by End Use, 2024
FIG 33 North America AI In Drug Repurposing Market share by End Use, 2032
FIG 34 North America AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 35 North America AI In Drug Repurposing Market share by Application, 2024
FIG 36 North America AI In Drug Repurposing Market share by Application, 2032
FIG 37 North America AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 38 North America AI In Drug Repurposing Market share by Country, 2024
FIG 39 North America AI In Drug Repurposing Market share by Country, 2032
FIG 40 North America AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 41 Key Factors Impacting Europe AI In Drug Repurposing Market
FIG 42 Europe AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 43 Europe AI In Drug Repurposing Market share by Component, 2024
FIG 44 Europe AI In Drug Repurposing Market share by Component, 2032
FIG 45 Europe AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 46 Europe AI In Drug Repurposing Market share by Technology, 2024
FIG 47 Europe AI In Drug Repurposing Market share by Technology, 2032
FIG 48 Europe AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 49 Europe AI In Drug Repurposing Market share by End Use, 2024
FIG 50 Europe AI In Drug Repurposing Market share by End Use, 2032
FIG 51 Europe AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 52 Europe AI In Drug Repurposing Market share by Application, 2024
FIG 53 Europe AI In Drug Repurposing Market share by Application, 2032
FIG 54 Europe AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 55 Europe AI In Drug Repurposing Market share by Country, 2024
FIG 56 Europe AI In Drug Repurposing Market share by Country, 2032
FIG 57 Europe AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 58 Key Factors Impacting asia pacific ai in drug repurposing Market
FIG 59 Asia Pacific AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 60 Asia Pacific AI In Drug Repurposing Market share by Component, 2024
FIG 61 Asia Pacific AI In Drug Repurposing Market share by Component, 2032
FIG 62 Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 63 Asia Pacific AI In Drug Repurposing Market share by Technology, 2024
FIG 64 Asia Pacific AI In Drug Repurposing Market share by Technology, 2032
FIG 65 Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 66 Asia Pacific AI In Drug Repurposing Market share by End Use, 2024
FIG 67 Asia Pacific AI In Drug Repurposing Market share by End Use, 2032
FIG 68 Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 69 Asia Pacific AI In Drug Repurposing Market share by Application, 2024
FIG 70 Asia Pacific AI In Drug Repurposing Market share by Application, 2032
FIG 71 Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 72 Asia Pacific AI In Drug Repurposing Market share by Country, 2024
FIG 73 Asia Pacific AI In Drug Repurposing Market share by Country, 2032
FIG 74 Asia Pacific AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 75 Key Factors Impacting lamea AI In Drug Repurposing Market
FIG 76 LAMEA AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 77 LAMEA AI In Drug Repurposing Market share by Component, 2024
FIG 78 LAMEA AI In Drug Repurposing Market share by Component, 2032
FIG 79 LAMEA AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 80 LAMEA AI In Drug Repurposing Market share by Technology, 2024
FIG 81 LAMEA AI In Drug Repurposing Market share by Technology, 2032
FIG 82 LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 83 LAMEA AI In Drug Repurposing Market share by End Use, 2024
FIG 84 LAMEA AI In Drug Repurposing Market share by End Use, 2032
FIG 85 LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 86 LAMEA AI In Drug Repurposing Market share by Application, 2024
FIG 87 LAMEA AI In Drug Repurposing Market share by Application, 2032
FIG 88 LAMEA AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 89 LAMEA AI In Drug Repurposing Market share by Country, 2024
FIG 90 LAMEA AI In Drug Repurposing Market share by Country, 2032
FIG 91 LAMEA AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 92 Swot Analysis: Ginkgo Bioworks
FIG 93 SWOT Analysis: IBM Corporation
FIG 94 SWOT Analysis: Novartis AG

Purchase Full Report of
AI In Drug Repurposing Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL

© 2025 KBV Research. All Rights Reserved